Summary

Clinical Decision Support System Market Research Report Information by Component (Software, Services, and Hardware) By Product (Integrated CDSS and Standalone CDSS), By Model (Knowledge-Based CDSS and Non-Knowledge-Based CDSS), By Delivery Mode (On-Premise CDSS and Cloud-Based CDSS), By Mode of Advice (Active CDSS and Passive CDSS), By Setting (Inpatient Settings and Ambulatory Care Settings) By Type (Therapeutic Clinical Decision Support Systems and Diagnostic Clinical Decision Support Systems ), By Application (Advanced Clinical Decision Support Systems and Conventional Clinical Decision Support Systems), By Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032

Market Overview
The clinical decision support system market is expected to increase from USD 3.67 billion in 2024 to USD 8.92 billion in 2032, with a compound annual growth rate (CAGR) of 10.54% throughout the forecast period. The growing aging population, favorable government regulations, and increased demand for data-driven technologies are all driving market expansion.
The older population is more susceptible to chronic ailments, necessitating regular medical examinations and treatments. As the senior population grows, so does the demand on healthcare facilities. This enhances the need for technology like CDSS to deliver efficient care. For example, the UN predicts that by 2050, one in every six persons worldwide would be beyond the age of 65, up from one in every eleven in 2019. According to the Rural Health Information Hub, the number of older persons in the United States aged 65 and up is predicted to reach nearly 90 million by 2050. Furthermore, by 2030, it is estimated that one in every five Americans will be 65 or older.

Market Segment insights
Clinical Decision Support System Market segmentation by component comprises software, services, and hardware.
The market is segmented based on product, which includes Integrated CDSS and Standalone CDSS.
The market is segmented using a methodology that incorporates both knowledge-based and non-knowledge-based CDSS.
The Clinical Decision Support System Market is segmented by delivery method, which includes both on-premises CDSS and cloud-based CDSS.
The market is segmented based on the mode of advice, which comprises both Active CDSS and passive CDSS.
The market is segmented by setting, which includes both inpatient and ambulatory care settings.
The Clinical Decision Support System Market is segmented by type, which includes both therapeutic and diagnostic clinical decision support systems.
The market is segmented based on application, which includes both sophisticated and conventional clinical decision support systems.
Regional insights
In 2023, North America held the biggest market share for clinical decision support systems. This is related to an increase in the prevalence of chronic diseases in North America, including cancer, cardiovascular ailments, diabetes, obesity, and arthritis.
Europe has the second-largest market share for clinical decision support systems due to the region's availability to modern treatment facilities.
The Asia-Pacific clinical decision support system market is expected to grow significantly because of factors such as improved healthcare infrastructure and an increasing patient population suffering from chronic diseases such as cancer, orthopedics, and cardiovascular disease.

Major Players
Siemens (Germany), Veradigm LLC (Allscripts Healthcare Solutions Inc) (US), Oracle Corporation (US), IBM (US), Carestream Health (US), Wolters Kluwer N.V. (Netherlands), Epic Systems Corporation (US), Chang Healthcare (US), Medical Information Technology, Inc. (US), and Computer Programs and Systems, Inc (US) are among the key players in the Clinical Decision Support System market.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA FLOW
3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
3.5.1 PRIMARY RESEARCH DATA FLOW:
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
3.7.1 DATA FORECASTING TECHNIQUE
3.8 DATA MODELING
3.8.1 MICROECONOMIC FACTOR ANALYSIS:
3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 RISING GERIATRIC POPULATION
4.2.2 FAVORABLE GOVERNMENT REGULATIONS
4.2.3 GROWING DEMAND FOR DATA-DRIVEN TECHNOLOGIES
4.3 RESTRAINT
4.3.1 RISK OF DATA PRIVACY
4.3.2 HIGH COST OF IMPLEMENTATION
4.4 OPPORTUNITIES
4.4.1 ADVANCEMENTS IN THE HEALTHCARE IT SECTOR
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 INPUTS
5.1.2 DESIGN & DEVELOPMENT
5.1.3 OUTPUT
5.1.4 SALES & DISTRIBUTION
5.1.5 POST-SALES SERVICES
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF BUYERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET
5.3.1 OVERVIEW
5.3.2 IMPACT ON SUPPLY CHAIN
5.3.3 IMPACT ON DEVELOPMENT
5.3.4 IMPACT ON REGIONS
5.3.5 MANAGING POST-COVID CARE THROUGH CLINICAL DECISION SUPPORT SYSTEMS
6 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 SOFTWARE
6.3 SERVICES
6.4 HARDWARE
7 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 INTEGRATED CDSS
7.3 STANDALONE CDSS
8 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL
8.1 OVERVIEW
8.2 KNOWLEDGE-BASED CDSS
8.3 NON-KNOWLEDGE-BASED CDSS
9 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE
9.1 OVERVIEW
9.2 ON-PREMISE CDSS
9.3 CLOUD-BASED CDSS
10 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE
10.1 OVERVIEW
10.2 ACTIVE CDSS
10.3 PASSIVE CDSS
11 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING
11.1 OVERVIEW
11.2 INPATIENT SETTINGS
11.3 AMBULATORY CARE SETTINGS
12 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE
12.1 OVERVIEW
12.2 THERAPEUTIC CDSS
12.3 DIAGNOSTIC CDSS
13 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION
13.1 OVERVIEW
13.2 ADVANCED CDSS
13.3 CONVENTIONAL CDSS
14 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY REGION
14.1 OVERVIEW
14.2 NORTH AMERICA
14.2.1 US
14.2.2 CANADA
14.3 EUROPE
14.3.1 GERMANY
14.3.2 FRANCE
14.3.3 UK
14.3.4 ITALY
14.3.5 SPAIN
14.3.6 REST OF EUROPE
14.4 ASIA-PACIFIC
14.4.1 CHINA
14.4.2 JAPAN
14.4.3 INDIA
14.4.4 AUSTRALIA
14.4.5 SOUTH KOREA
14.4.6 REST OF ASIA-PACIFIC
14.5 REST OF THE WORLD
14.5.1 MIDDLE EAST & AFRICA
14.5.2 LATIN AMERICA
15 COMPETITIVE LANDSCAPE
15.1 INTRODUCTION
15.2 MARKET SHARE ANALYSIS, 2023
15.3 COMPETITOR DASHBOARD
15.4 PUBLIC PLAYERS STOCK SUMMARY
15.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
15.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
15.6.1 /PRODUCT/SOLUTION/SERVICE LAUNCHAPPROVAL
15.6.2 COLLABORATION
15.6.3 ACQUISITION
15.6.4 PARTNERSHIP
16 COMPANY PROFILES
16.1 SIEMENS
16.1.1 COMPANY OVERVIEW
16.1.2 FINANCIAL OVERVIEW
16.1.3 PRODUCTS OFFERED
16.1.4 KEY DEVELOPMENTS
16.1.5 SWOT ANALYSIS
16.1.6 KEY STRATEGIES
16.2 VERADIGM LLC (ALLSCRIPTS HEALTHCARE SOLUTIONS INC)
16.2.1 COMPANY OVERVIEW
16.2.2 FINANCIAL OVERVIEW
16.2.3 PRODUCTS OFFERED
16.2.4 KEY DEVELOPMENTS
16.2.5 SWOT ANALYSIS
16.2.6 KEY STRATEGIES
16.3 ORACLE CORPORATION
16.3.1 COMPANY OVERVIEW
16.3.2 FINANCIAL OVERVIEW
16.3.3 PRODUCTS OFFERED
16.3.4 KEY DEVELOPMENTS
16.3.5 KEY STRATEGIES
16.4 IBM
16.4.1 COMPANY OVERVIEW
16.4.2 FINANCIAL OVERVIEW
16.4.3 SOLUTION OFFERED
16.4.4 KEY DEVELOPMENTS
16.4.5 SWOT ANALYSIS
16.4.6 KEY STRATEGIES
16.5 CARESTREAM HEALTH
16.5.1 COMPANY OVERVIEW
16.5.2 FINANCIAL OVERVIEW
16.5.3 SERVICE/SOLUTION OFFERED
16.5.4 KEY DEVELOPMENTS
16.5.5 KEY STRATEGIES
16.6 WOLTERS KLUWER N.V.
16.6.1 COMPANY OVERVIEW
16.6.2 FINANCIAL OVERVIEW
16.6.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
16.6.4 KEY DEVELOPMENTS
16.6.5 SWOT ANALYSIS
16.6.6 KEY STRATEGIES
16.7 EPIC SYSTEMS CORPORATION
16.7.1 COMPANY OVERVIEW
16.7.2 FINANCIAL OVERVIEW
16.7.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
16.7.4 KEY DEVELOPMENTS
16.7.5 SWOT ANALYSIS
16.7.6 KEY STRATEGIES
16.8 CHANG HEALTHCARE
16.8.1 COMPANY OVERVIEW
16.8.2 FINANCIAL OVERVIEW
16.8.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
16.8.4 KEY DEVELOPMENTS
16.8.5 KEY STRATEGIES
16.9 MEDICAL INFORMATION TECHNOLOGY, INC.
16.9.1 COMPANY OVERVIEW
16.9.2 FINANCIAL OVERVIEW
16.9.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
16.9.4 KEY DEVELOPMENTS
16.9.5 KEY STRATEGIES
16.10 COMPUTER PROGRAMS AND SYSTEMS, INC.
16.10.1 COMPANY OVERVIEW
16.10.2 FINANCIAL OVERVIEW
16.10.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
16.10.4 KEY DEVELOPMENTS
16.10.5 KEY STRATEGIES
17 DATA CITATIONS